Interferon Nasal Spray Shows Protective Effect Against COVID-19
Daily prophylaxis with interferon-alpha (IFN-α) nasal spray significantly reduced the risk of COVID-19 infection in adult patients with cancer, according to findings from a randomized, double-blinded, placebo-controlled trial.